Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0026827 (
hypotonia
)
5,860
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Mulibrey nanism (for muscle-liver-brain-eye nanism,
MUL
; MIM 253250) is an autosomal recessive disorder that involves several tissues of mesodermal origin, implying a defect in a highly pleiotropic gene. Characteristic features include severe growth failure of prenatal onset and constrictive pericardium with consequent hepatomegaly. In addition, muscle
hypotonia
, J-shaped sella turcica, yellowish dots in the ocular fundi, typical dysmorphic features and hypoplasia of various endocrine glands causing hormonal deficiency are common. About 4% of
MUL
patients develop Wilms' tumour.
MUL
is enriched in the Finnish population, but is rare elsewhere. We previously assigned
MUL
to chromosome 17q22-q23 and constructed a physical contig over the critical
MUL
region. The region has now been further refined by haplotype analysis and new positional candidate genes have been localized. We identified a gene with four independent
MUL
-associated mutations that all cause a frameshift and predict a truncated protein.
MUL
is ubiquitously expressed and encodes a new member of the RING-B-box-Coiled-coil (RBCC) family of zinc-finger proteins, whose members are involved in diverse cellular functions such as developmental patterning and oncogenesis.
...
PMID:Gene encoding a new RING-B-box-Coiled-coil protein is mutated in mulibrey nanism. 1088 77